时间
|
序号
|
编号
|
题目
|
演讲人
|
16:00-16:20
|
1
|
S1-1
|
Modifiable Risk Factors for Age-related Macular Degeneration (AMD): Population-based Study Findings |
Jie Jin Wang University of Sydney |
16:20-16:40
|
2
|
S1-2
|
LOC387715 is associated with increased risk of neovascular age-related macular degeneration in the Utah population |
Kang Zhang University of Utah, USA |
16:40-17:00
|
3
|
S1-3
|
The PDT Treatment for AMD in China |
陆方 四川大学华西医院 |
17:00-17:20
|
4
|
S1-4
|
Ciliary Neurotrophic Factor (CNTF) Phase 1 Clinical Trial for Retinal and Macular Degeneration |
Paul A. Sieving NEI,USA |
17:20-17:40
|
5
|
S1-5
|
Development of Retinal Degeneration in Adult CCL2/CX3CR1 Deficient Mice: a Model of Age-Related Macular Degeneration |
Jingsheng Tuo NEI,USA |
17:40-18:00
|
|
|
讨论 |
|